MARY ALAMSHAHI: Open Payments
NPI 1861465940 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,067 in 15 payments from 7 companies in 2025. Trend: 2023 $749 · 2024 $684 · 2025 $1,067
Food & beverage: $1,067
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $271 |
| GENZYME CORPORATION | 2 | $237 |
| Baxter Healthcare | 3 | $152 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Verona Pharma, Inc. | 1 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $94 |
| Merck Sharp & Dohme LLC | 1 | $75 |
Products named: NUCALA, DUPIXENT, Hillrom - Vest System Model 105 Home Care, AIRSUPRA, Ohtuvayre, WINREVAIR.
Industry payments across CA — which companies pay providers there.
